However CCR2 expression on KCs is absent under healthy conditions, but increases in parallel to disease evolution, serving as diagnostic marker in the context of NAFLD (Krenkel et al., 2018). This evidence concerns the gene CCR2 and metabolic dysfunction-associated steatotic liver disease.